Samsung Biologics Co.,Ltd. (KOSE: A207940)
Health Care · Life Sciences Tools & Services · KR
₩1,219,000.00
-9.97% today · +19.5% 1Y
Samsung Biologics Co.,Ltd. (KOSE: A207940) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $41.93B.
Over the last twelve months the share price has gained 19.5%, trading between 1.22M and 1.99M.
Tweenvest scores Samsung Biologics Co.,Ltd. across four factors: quality 77/100, value 73/100, growth 97/100. Its strongest factor is growth.
A207940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $41.93B
- Revenue (TTM)
- $3.31B
- P/E
- 28.71
- EPS
- 45,556.40
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- ₩1,987,000.00
- 52-week low
- ₩1,218,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 46.24M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Agilent Technologies, Inc.NYSE: A | $48.08B | $171.67 | +0.66% |
| IQVIA Holdings Inc.NYSE: IQV | $42.78B | $261.57 | +0.65% |
| Waters CorporationNYSE: WAT | $42.62B | $430.59 | -0.73% |
| Illumina, Inc.NasdaqGS: ILMN | $42.00B | $272.66 | -1.98% |
| Mettler-Toledo International Inc.NYSE: MTD | $31.06B | $1,560.21 | +0.66% |
| WuXi Biologics (Cayman) Inc.SEHK: 2269 | $28.16B | HK$53.85 | -0.46% |
| West Pharmaceutical Services, Inc.NYSE: WST | $25.76B | $370.09 | +1.12% |
| Divi's Laboratories LimitedNSEI: DIVISLAB | $25.62B | Rs9,340.00 | +0.98% |
Figures last refreshed Oct 11, 2026.